Medable Partners and Pluto Health team up improve clinical trial data and experience
The two companies will work together to connect patients to the right medical resources
Thanks to the pandemic, the decentralized clinical trial space went from a fairly niche to seeing heavy investor interest and growth; of those companies, as it became important for trials to be conducted outside of the hospitals and medical offices that were now closed.
Of all the companies in the space, Medable perhaps benefitted the most, raising four funding rounds in 18 months, including one that valued it at over $2 billion.
Now it will be even easier for patients to share their data thanks to a newly announced enterprise partnership with smart care coordination services company Pluto Health. The two companies will work together to connect patients to the right medical resources, from access to a clinical trial to getting medications delivered directly to their doors.
Pluto Health unifies health information from many places to understand next steps and best care options, fetching records and insurance information within minutes without the need for patients to remember provider names or health centers, or portal usernames or passwords. Its clinical team creates personalized plans, coordinates services, and connects to resources to address care gaps. It also provides curated recommendations on preventive health support, medication management, labwork, referrals to providers, clinical trials, and prescriptions delivery.
The company has so far helped monitor and close nearly 500,000 care gaps, including missing preventive health immunizations to assistance with colon cancer screenings. Currently, the platform is not delivered to patients individually but through health partners as a health service.
Medable, meanwhile, offers its clients, which include clinical trial sponsors, such as pharma and biotech companies, as well as clinical research organizations who manage trials for those companies, features that include patient identification and site selection through AI and machine learning; digitized patient enrollment; and the ability to do trials in any country and in any language. It also provides them with remote patient monitoring, and the ability to see streaming data and patient data in real-time.
The company has deployed its software-as-a-service platform in more than 300 decentralized and hybrid clinical trials in 60 countries, serving more than one million patients and research participants globally. Its customers have seen 200% faster enrollment and 50% cost reductions.
In addition to improving the patient experience, Medable and Pluto Health also plan to work together to make it easier for study teams to access relevant patient information and improve data quality as well as facilitate long-term follow-up with patients post trial. Additionally, patents will be able to opt-in to receive real-time notifications of medically relevant future clinical trial opportunities.
“Our partnership is primarily a win for patients, alongside other stakeholders, who will benefit from ongoing enhanced support,” Dr. Joy Bhosai, Pluto Health’s CEO and founder, said in a statement.
“Pluto is passionate about improving patient care in communities and designing systems that deliver resources for patients to manage health needs over time, especially if they are going through a clinical trial as part of a care option. We are excited for what the future holds with Medable.”
(Image source: pluto.health)
Related News
October 26, 2021
Medable raises another $304 million, valuing it at over $2 billion
September 7, 2022